An issue has been identified in the MDS 3.0 Resident-Level Quality Measure (QM) Report where the footnote for the MDS Hybrid Measure Antipsychotic Med (L) is displaying the incorrect 3-month reporting period when an End Date after 09/30/2025 is requested. Currently, if the requested End Date is set to on or after 10/01/2025, then the report displays data for the latest available 3-month period which is Q3 2025 (07/01/2025 – 09/30/2025). When the issue is addressed, the footnote should correctly display the following: “The Percent of Long-Stay Residents Who Received an Antipsychotic Medication measure is calculated using MDS, Medicare and Medicaid claims and is based on 3 months of data (07/01/2025 – 09/30/2025).”